CWA Asset Management Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,672
Closed -$213K 328
2021
Q3
$213K Sell
3,672
-14
-0.4% -$863 0.02% 262
2021
Q2
$236K Buy
+3,686
New +$243K 0.02% 250
2020
Q2
Sell
-80,638
Closed -$3.13M 262
2020
Q1
$3.13M Buy
80,638
+5,218
+7% +$266K 0.6% 49
2019
Q4
$4.27M Buy
75,420
+2,289
+3% +$128K 0.69% 54
2019
Q3
$3.9M Buy
73,131
+7,349
+11% +$395K 0.63% 57
2019
Q2
$3.84M Buy
65,782
+7,240
+12% +$389K 0.66% 52
2019
Q1
$2.9M Buy
58,542
+18,280
+45% +$805K 0.56% 57
2018
Q4
$1.5M Buy
40,262
+2,570
+7% +$93.5K 0.35% 72
2018
Q3
$1.42M Buy
+37,692
New +$1.57M 0.31% 75

Other funds holding XRAY

CWA Asset Management Group's XRAY Position: Q4 2021 in Review

CWA Asset Management Group sold out of Dentsply Sirona (XRAY) in Q4 2021, closing a stake of 3,672 shares — an estimated $213K sold.

CWA Asset Management Group first reported a position in XRAY in Q3 2018 and held it in 9 quarters. The position peaked at $4.27M in Q4 2019. 542 funds tracked by Wall St. Rank hold XRAY as of Q4 2021.

  • CWA Asset Management Group reported no remaining Dentsply Sirona position as of Q4 2021 after selling out during the quarter.
  • CWA Asset Management Group sold 3,672 Dentsply Sirona shares in Q4 2021, an estimated $213K.
  • CWA Asset Management Group first reported a position in Dentsply Sirona in Q3 2018 and held it in 9 quarters.
  • CWA Asset Management Group's Dentsply Sirona position peaked at $4.27M in Q4 2019.
  • 542 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2021.

Based on CWA Asset Management Group's 13F filing for Q4 2021, filed 15 Feb 2022.